カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の乾燥症候群治療薬市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Sicca Syndrome Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	■ 発行会社/調査会社：GlobalInfoResearch ■ 商品コード：GIR22NO19629 ■ 発行日：2022年11月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医薬品 ■ ページ数：103 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（注文後2-3日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の乾燥症候群治療薬市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

乾燥症候群治療薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の乾燥症候群治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

乾燥症候群治療薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の乾燥症候群治療薬市場の主要な市場プレーヤーは以下のとおりです。
・Akari Therapeutics, Plc、Amgen Inc.、Ampio Pharmaceuticals, Inc.、Biogen, Inc.、Bristol-Myers Squibb Company、GlaxoSmithKline Plc、MedImmune, LLC、Novartis AG、Redx Pharma Plc、Toleranzia AB、UCB S.A.

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、乾燥症候群治療薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な乾燥症候群治療薬メーカーの企業概要、2019年～2022年までの乾燥症候群治療薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な乾燥症候群治療薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別乾燥症候群治療薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの乾燥症候群治療薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での乾燥症候群治療薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および乾燥症候群治療薬の産業チェーンを掲載しています。
・第13、14、15章では、乾燥症候群治療薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 乾燥症候群治療薬の概要
- 種類別分析（2017年vs2021年vs2028年）：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の乾燥症候群治療薬市場規模・予測
- 世界の乾燥症候群治療薬生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Akari Therapeutics, Plc、Amgen Inc.、Ampio Pharmaceuticals, Inc.、Biogen, Inc.、Bristol-Myers Squibb Company、GlaxoSmithKline Plc、MedImmune, LLC、Novartis AG、Redx Pharma Plc、Toleranzia AB、UCB S.A.
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：BMS-986142、ベリムマブ、カバシン、フィルゴチニブ、LY-3090106、その他
・用途別分析2017年-2028年：病院、診療所、その他
・乾燥症候群治療薬の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・乾燥症候群治療薬のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・乾燥症候群治療薬のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・乾燥症候群治療薬の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・乾燥症候群治療薬の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Sicca Syndrome Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Sicca Syndrome Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Sicca Syndrome Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While BMS-986142 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Sicca Syndrome Drug include Akari Therapeutics, Plc, Amgen Inc., Ampio Pharmaceuticals, Inc., Biogen, Inc., and Bristol-Myers Squibb Company, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Sicca Syndrome Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
BMS-986142
Belimumab
Coversin
Filgotinib
LY-3090106
Others
Market segment by Application can be divided into
Hospital
Clinic
Others
The key market players for global Sicca Syndrome Drug market are listed below:
Akari Therapeutics, Plc
Amgen Inc.
Ampio Pharmaceuticals, Inc.
Biogen, Inc.
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
MedImmune, LLC
Novartis AG
Redx Pharma Plc
Toleranzia AB
UCB S.A.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sicca Syndrome Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sicca Syndrome Drug, with price, sales, revenue and global market share of Sicca Syndrome Drug from 2019 to 2022.
Chapter 3, the Sicca Syndrome Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sicca Syndrome Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Sicca Syndrome Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sicca Syndrome Drug.
Chapter 13, 14, and 15, to describe Sicca Syndrome Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Sicca Syndrome Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sicca Syndrome Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 BMS-986142
1.2.3 Belimumab
1.2.4 Coversin
1.2.5 Filgotinib
1.2.6 LY-3090106
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sicca Syndrome Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sicca Syndrome Drug Market Size & Forecast
1.4.1 Global Sicca Syndrome Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Sicca Syndrome Drug Sales in Volume (2017-2028)
1.4.3 Global Sicca Syndrome Drug Price (2017-2028)
1.5 Global Sicca Syndrome Drug Production Capacity Analysis
1.5.1 Global Sicca Syndrome Drug Total Production Capacity (2017-2028)
1.5.2 Global Sicca Syndrome Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sicca Syndrome Drug Market Drivers
1.6.2 Sicca Syndrome Drug Market Restraints
1.6.3 Sicca Syndrome Drug Trends Analysis
2 Manufacturers Profiles
2.1 Akari Therapeutics, Plc
2.1.1 Akari Therapeutics, Plc Details
2.1.2 Akari Therapeutics, Plc Major Business
2.1.3 Akari Therapeutics, Plc Sicca Syndrome Drug Product and Services
2.1.4 Akari Therapeutics, Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Amgen Inc.
2.2.1 Amgen Inc. Details
2.2.2 Amgen Inc. Major Business
2.2.3 Amgen Inc. Sicca Syndrome Drug Product and Services
2.2.4 Amgen Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Ampio Pharmaceuticals, Inc.
2.3.1 Ampio Pharmaceuticals, Inc. Details
2.3.2 Ampio Pharmaceuticals, Inc. Major Business
2.3.3 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product and Services
2.3.4 Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Biogen, Inc.
2.4.1 Biogen, Inc. Details
2.4.2 Biogen, Inc. Major Business
2.4.3 Biogen, Inc. Sicca Syndrome Drug Product and Services
2.4.4 Biogen, Inc. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bristol-Myers Squibb Company
2.5.1 Bristol-Myers Squibb Company Details
2.5.2 Bristol-Myers Squibb Company Major Business
2.5.3 Bristol-Myers Squibb Company Sicca Syndrome Drug Product and Services
2.5.4 Bristol-Myers Squibb Company Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline Plc
2.6.1 GlaxoSmithKline Plc Details
2.6.2 GlaxoSmithKline Plc Major Business
2.6.3 GlaxoSmithKline Plc Sicca Syndrome Drug Product and Services
2.6.4 GlaxoSmithKline Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 MedImmune, LLC
2.7.1 MedImmune, LLC Details
2.7.2 MedImmune, LLC Major Business
2.7.3 MedImmune, LLC Sicca Syndrome Drug Product and Services
2.7.4 MedImmune, LLC Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Sicca Syndrome Drug Product and Services
2.8.4 Novartis AG Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Redx Pharma Plc
2.9.1 Redx Pharma Plc Details
2.9.2 Redx Pharma Plc Major Business
2.9.3 Redx Pharma Plc Sicca Syndrome Drug Product and Services
2.9.4 Redx Pharma Plc Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Toleranzia AB
2.10.1 Toleranzia AB Details
2.10.2 Toleranzia AB Major Business
2.10.3 Toleranzia AB Sicca Syndrome Drug Product and Services
2.10.4 Toleranzia AB Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 UCB S.A.
2.11.1 UCB S.A. Details
2.11.2 UCB S.A. Major Business
2.11.3 UCB S.A. Sicca Syndrome Drug Product and Services
2.11.4 UCB S.A. Sicca Syndrome Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Sicca Syndrome Drug Breakdown Data by Manufacturer
3.1 Global Sicca Syndrome Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Sicca Syndrome Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Sicca Syndrome Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Sicca Syndrome Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Sicca Syndrome Drug Manufacturer Market Share in 2021
3.5 Global Sicca Syndrome Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Sicca Syndrome Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sicca Syndrome Drug Market Size by Region
4.1.1 Global Sicca Syndrome Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Sicca Syndrome Drug Revenue by Region (2017-2028)
4.2 North America Sicca Syndrome Drug Revenue (2017-2028)
4.3 Europe Sicca Syndrome Drug Revenue (2017-2028)
4.4 Asia-Pacific Sicca Syndrome Drug Revenue (2017-2028)
4.5 South America Sicca Syndrome Drug Revenue (2017-2028)
4.6 Middle East and Africa Sicca Syndrome Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Sicca Syndrome Drug Sales in Volume by Type (2017-2028)
5.2 Global Sicca Syndrome Drug Revenue by Type (2017-2028)
5.3 Global Sicca Syndrome Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Sicca Syndrome Drug Sales in Volume by Application (2017-2028)
6.2 Global Sicca Syndrome Drug Revenue by Application (2017-2028)
6.3 Global Sicca Syndrome Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Sicca Syndrome Drug Sales by Type (2017-2028)
7.2 North America Sicca Syndrome Drug Sales by Application (2017-2028)
7.3 North America Sicca Syndrome Drug Market Size by Country
7.3.1 North America Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Sicca Syndrome Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Sicca Syndrome Drug Sales by Type (2017-2028)
8.2 Europe Sicca Syndrome Drug Sales by Application (2017-2028)
8.3 Europe Sicca Syndrome Drug Market Size by Country
8.3.1 Europe Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Sicca Syndrome Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Sicca Syndrome Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Sicca Syndrome Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Sicca Syndrome Drug Market Size by Region
9.3.1 Asia-Pacific Sicca Syndrome Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Sicca Syndrome Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Sicca Syndrome Drug Sales by Type (2017-2028)
10.2 South America Sicca Syndrome Drug Sales by Application (2017-2028)
10.3 South America Sicca Syndrome Drug Market Size by Country
10.3.1 South America Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Sicca Syndrome Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sicca Syndrome Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Sicca Syndrome Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Sicca Syndrome Drug Market Size by Country
11.3.1 Middle East & Africa Sicca Syndrome Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Sicca Syndrome Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Sicca Syndrome Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Sicca Syndrome Drug
12.3 Sicca Syndrome Drug Production Process
12.4 Sicca Syndrome Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Sicca Syndrome Drug Typical Distributors
13.3 Sicca Syndrome Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Sicca Syndrome Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Sicca Syndrome Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Akari Therapeutics, Plc Basic Information, Manufacturing Base and Competitors
Table 4. Akari Therapeutics, Plc Major Business
Table 5. Akari Therapeutics, Plc Sicca Syndrome Drug Product and Services
Table 6. Akari Therapeutics, Plc Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Amgen Inc. Major Business
Table 9. Amgen Inc. Sicca Syndrome Drug Product and Services
Table 10. Amgen Inc. Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Ampio Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Ampio Pharmaceuticals, Inc. Major Business
Table 13. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Product and Services
Table 14. Ampio Pharmaceuticals, Inc. Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Biogen, Inc. Basic Information, Manufacturing Base and Competitors
Table 16. Biogen, Inc. Major Business
Table 17. Biogen, Inc. Sicca Syndrome Drug Product and Services
Table 18. Biogen, Inc. Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 20. Bristol-Myers Squibb Company Major Business
Table 21. Bristol-Myers Squibb Company Sicca Syndrome Drug Product and Services
Table 22. Bristol-Myers Squibb Company Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Plc Major Business
Table 25. GlaxoSmithKline Plc Sicca Syndrome Drug Product and Services
Table 26. GlaxoSmithKline Plc Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 28. MedImmune, LLC Major Business
Table 29. MedImmune, LLC Sicca Syndrome Drug Product and Services
Table 30. MedImmune, LLC Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 32. Novartis AG Major Business
Table 33. Novartis AG Sicca Syndrome Drug Product and Services
Table 34. Novartis AG Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Redx Pharma Plc Basic Information, Manufacturing Base and Competitors
Table 36. Redx Pharma Plc Major Business
Table 37. Redx Pharma Plc Sicca Syndrome Drug Product and Services
Table 38. Redx Pharma Plc Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Toleranzia AB Basic Information, Manufacturing Base and Competitors
Table 40. Toleranzia AB Major Business
Table 41. Toleranzia AB Sicca Syndrome Drug Product and Services
Table 42. Toleranzia AB Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. UCB S.A. Basic Information, Manufacturing Base and Competitors
Table 44. UCB S.A. Major Business
Table 45. UCB S.A. Sicca Syndrome Drug Product and Services
Table 46. UCB S.A. Sicca Syndrome Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Sicca Syndrome Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 48. Global Sicca Syndrome Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Sicca Syndrome Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Sicca Syndrome Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Sicca Syndrome Drug Production Site of Key Manufacturer
Table 52. Sicca Syndrome Drug New Entrant and Capacity Expansion Plans
Table 53. Sicca Syndrome Drug Mergers & Acquisitions in the Past Five Years
Table 54. Global Sicca Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 55. Global Sicca Syndrome Drug Sales by Region (2023-2028) & (K Pcs)
Table 56. Global Sicca Syndrome Drug Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Sicca Syndrome Drug Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 59. Global Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 60. Global Sicca Syndrome Drug Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Sicca Syndrome Drug Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Sicca Syndrome Drug Price by Type (2017-2022) & (USD/Pcs)
Table 63. Global Sicca Syndrome Drug Price by Type (2023-2028) & (USD/Pcs)
Table 64. Global Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 65. Global Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 66. Global Sicca Syndrome Drug Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Sicca Syndrome Drug Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Sicca Syndrome Drug Price by Application (2017-2022) & (USD/Pcs)
Table 69. Global Sicca Syndrome Drug Price by Application (2023-2028) & (USD/Pcs)
Table 70. North America Sicca Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 71. North America Sicca Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 72. North America Sicca Syndrome Drug Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Sicca Syndrome Drug Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 75. North America Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 76. North America Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 77. North America Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 78. Europe Sicca Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 79. Europe Sicca Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 80. Europe Sicca Syndrome Drug Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Sicca Syndrome Drug Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 83. Europe Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 84. Europe Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 85. Europe Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 86. Asia-Pacific Sicca Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 87. Asia-Pacific Sicca Syndrome Drug Sales by Region (2023-2028) & (K Pcs)
Table 88. Asia-Pacific Sicca Syndrome Drug Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Sicca Syndrome Drug Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 91. Asia-Pacific Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 92. Asia-Pacific Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 93. Asia-Pacific Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 94. South America Sicca Syndrome Drug Sales by Country (2017-2022) & (K Pcs)
Table 95. South America Sicca Syndrome Drug Sales by Country (2023-2028) & (K Pcs)
Table 96. South America Sicca Syndrome Drug Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Sicca Syndrome Drug Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 99. South America Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 100. South America Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 101. South America Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 102. Middle East & Africa Sicca Syndrome Drug Sales by Region (2017-2022) & (K Pcs)
Table 103. Middle East & Africa Sicca Syndrome Drug Sales by Region (2023-2028) & (K Pcs)
Table 104. Middle East & Africa Sicca Syndrome Drug Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Sicca Syndrome Drug Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Sicca Syndrome Drug Sales by Type (2017-2022) & (K Pcs)
Table 107. Middle East & Africa Sicca Syndrome Drug Sales by Type (2023-2028) & (K Pcs)
Table 108. Middle East & Africa Sicca Syndrome Drug Sales by Application (2017-2022) & (K Pcs)
Table 109. Middle East & Africa Sicca Syndrome Drug Sales by Application (2023-2028) & (K Pcs)
Table 110. Sicca Syndrome Drug Raw Material
Table 111. Key Manufacturers of Sicca Syndrome Drug Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Sicca Syndrome Drug Typical Distributors
Table 115. Sicca Syndrome Drug Typical Customers
List of Figures
Figure 1. Sicca Syndrome Drug Picture
Figure 2. Global Sicca Syndrome Drug Revenue Market Share by Type in 2021
Figure 3. BMS-986142
Figure 4. Belimumab
Figure 5. Coversin
Figure 6. Filgotinib
Figure 7. LY-3090106
Figure 8. Others
Figure 9. Global Sicca Syndrome Drug Revenue Market Share by Application in 2021
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Sicca Syndrome Drug Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 14. Global Sicca Syndrome Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Sicca Syndrome Drug Sales (2017-2028) & (K Pcs)
Figure 16. Global Sicca Syndrome Drug Price (2017-2028) & (USD/Pcs)
Figure 17. Global Sicca Syndrome Drug Production Capacity (2017-2028) & (K Pcs)
Figure 18. Global Sicca Syndrome Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Sicca Syndrome Drug Market Drivers
Figure 20. Sicca Syndrome Drug Market Restraints
Figure 21. Sicca Syndrome Drug Market Trends
Figure 22. Global Sicca Syndrome Drug Sales Market Share by Manufacturer in 2021
Figure 23. Global Sicca Syndrome Drug Revenue Market Share by Manufacturer in 2021
Figure 24. Sicca Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Sicca Syndrome Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Sicca Syndrome Drug Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Sicca Syndrome Drug Sales Market Share by Region (2017-2028)
Figure 28. Global Sicca Syndrome Drug Revenue Market Share by Region (2017-2028)
Figure 29. North America Sicca Syndrome Drug Revenue (2017-2028) & (USD Million)
Figure 30. Europe Sicca Syndrome Drug Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Sicca Syndrome Drug Revenue (2017-2028) & (USD Million)
Figure 32. South America Sicca Syndrome Drug Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Sicca Syndrome Drug Revenue (2017-2028) & (USD Million)
Figure 34. Global Sicca Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 35. Global Sicca Syndrome Drug Revenue Market Share by Type (2017-2028)
Figure 36. Global Sicca Syndrome Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 37. Global Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 38. Global Sicca Syndrome Drug Revenue Market Share by Application (2017-2028)
Figure 39. Global Sicca Syndrome Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 40. North America Sicca Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 41. North America Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 42. North America Sicca Syndrome Drug Sales Market Share by Country (2017-2028)
Figure 43. North America Sicca Syndrome Drug Revenue Market Share by Country (2017-2028)
Figure 44. United States Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Sicca Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 48. Europe Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 49. Europe Sicca Syndrome Drug Sales Market Share by Country (2017-2028)
Figure 50. Europe Sicca Syndrome Drug Revenue Market Share by Country (2017-2028)
Figure 51. Germany Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Sicca Syndrome Drug Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Sicca Syndrome Drug Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Sicca Syndrome Drug Revenue Market Share by Region (2017-2028)
Figure 60. China Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Sicca Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 67. South America Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 68. South America Sicca Syndrome Drug Sales Market Share by Country (2017-2028)
Figure 69. South America Sicca Syndrome Drug Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Sicca Syndrome Drug Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Sicca Syndrome Drug Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Sicca Syndrome Drug Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Sicca Syndrome Drug Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Sicca Syndrome Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Sicca Syndrome Drug in 2021
Figure 81. Manufacturing Process Analysis of Sicca Syndrome Drug
Figure 82. Sicca Syndrome Drug Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

世界の乾燥症候群治療薬市場2022年：市場規模予測（～2028年）

グローバル市場調査会社